Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OCTREOTIDE ACETATE USP (PROCESS-II), with a corresponding US DMF Number 27990.
Remarkably, this DMF maintains an Active status since its submission on March 01, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 05, 2014, and payment made on February 21, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II